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The rapid development of molecular biology techniques in
the last three decades has seen a powerful shift from classical
cytogenetics to chip technologies and deep sequencing of
whole tumour genomes. Today, several relatively low-cost
technologies enable us to study whole tumour genomes and
gather information about a tumour’s genomic, transcripteomic
and proteomic profile almost overnight. More technologies,
such as chromatin, methylation and micro-RNA chips, will soon
become mainstream analysis in many pathology laboratories.
Against this backdrop, this book summarises cytogenetic
information on neural tumours, and hence concludes an era of
molecular profiling of cancer.
The book title promises to cover neural tumours. Slightly
unusually, however, the authors excluded several important
entities of bona fide neural tumours, such as gliomas, neuronal
tumours and mixed neuronal-glial tumours, which form a large
proportion of brain tumours. Instead, ‘non-neural’ tumours such
as meningiomas, hemangioblastomas and paragangliomas are
included in this book.
The book therefore essentially covers nerve sheath tumours,
meningiomas, hemangioblastomas, neuroendocrine tumours as
well as a mixed group of neuroblastic and primitive neuro-
ectodermal tumours. The book is written very systematically, in
that every chapter contains an overview on each tumour type and
then describes the most relevant chromosomal changes. Every
chapter also contains very extensive and very well referenced
tables. The meticulous listings of all chromosomal abnormalities
that have to date been reported for these tumours are probably
unmatched in the literature. In addition, the key literature is
summarised by a brief one-line summary that is compiled to a
large table with references. Further, this cytogenetics reference
book shows karyotype reprints, comparative genomic hybridisa-
tion schematics and the typical histological appearance of those
tumours. There is also a very systematic description of molecular
signalling pathways and Kaplan–Meier survival curves to illustrate
the relevance of a certain mutation to the prognosis of the
tumours.
When I started reading this book, I was full of expectations
about the molecular genetic changes in tumours and anticipated
furthering my understanding of their pathogenesis. Having seen
in the introduction a reference to a possible comparison to
animal models, I expected a correlation of (mostly, but not
exclusively, mouse) model systems with the human counterpart.
The book meets my expectations regarding the description of
signalling pathways relevant to human tumours, but I was
disappointed to find very little reference to animal models,
which have significantly contributed to the advancement of our
understanding of tumour pathogenesis. Another disappointing
feature of this book is the lack of colour prints. Although this can
be tolerated for histological photographs, which are not a focus
of this book, a three-colour illustration of pathways and other
schematics would have improved the overall appearance con-
siderably. Moreover, some of the halftone reproduction is of
poor quality and I am somewhat surprised about the lack of
attention to the drawings. For example, the pathways are often
not presented very clearly, making it sometimes difficult to
understand and to follow the positive or negative feedback
mechanisms. Also, the relevance of gain of function or loss of
function should have been illustrated in this context.
Although the tables are useful as a reference, they are sometimes
very hard to read, in particular with multiple chromosomal gains
and losses. A table in which each box is reserved for a specific
chromosome (semi-graphical representation) might have im-
proved the legibility.
Beyond these issues that relate to graphical editing and may be
regarded as less important by some readers, the lack of reference to
most recent technologies such as SNP analysis, deep sequencing
and expression array analysis with relation to the existing
cytogenetic findings appears perhaps more significant. Meanwhile,
there are a number of databases that are publicly accessible and
from which a wealth of data can be downloaded and analysed. An
overview would have been helpful in delineating the future
potential of these novel technologies.
In conclusion, this volume surprisingly omits most primary CNS
tumours (except medulloblastoma), which is slightly confusing as
these are typically and primarily referred to as ‘neural tumours’.
The book serves well as a data repository with an enumeration and
listing of karyotypes, chromosomal aberrations and a detailed
description of the pathways involved in the pathogenesis of these
tumours. What I miss in this book is a reference to model systems,
many of which have been key to the understanding of the
histogenesis and molecular pathogenesis of many human brain
tumours. This deficiency becomes particularly apparent in the
chapter ‘medulloblastoma’ for which a wealth of mouse models has
been generated over the last decade. A thorough and systematic
comparison of the pathways and cells involved in the pathogenesis
would have been very informative. Also surprisingly, the authors
have referred to the old WHO classification (2000) rather than
referring to the revised classification of 2007, which has seen
important changes to the terminology and classification of
primitive neuroectodermal tumours, neuroblastoma and medullo-
blastoma.
I recommend this book as a reference manual for cytogeneti-
cists, but may not recommend it to my students or research
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www.bjcancer.comfellows who not only need to understand the correlation
between molecular events and tumour pathogenesis but
importantly also need inspiration and vision for their own
research.
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